Chiron Investment Management’s Gilead Sciences GILD Stock Holding History

Chiron Investment Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-415	Closed	-$32K	–	95
2023 Q2	$32K	Hold	415	–	–	0.01%	122
2023 Q1	$34.4K	Hold	415	–	–	0.01%	125
2022 Q4	$35.6K	Buy	+415	New	+$32.9K	0.01%	122
2020 Q1	–	Sell	-395,799	Closed	-$25.7M	–	66
2019 Q4	$25.7M	Sell	395,799 -215,466	-35%	-$14M	3.63%	6
2019 Q3	$38.7M	Buy	611,265 +31,300	+5%	+$2.05M	5.93%	3
2019 Q2	$39.2M	Buy	579,965 +19,404	+3%	+$1.28M	8.13%	3
2019 Q1	$36.4M	Sell	560,561 -111,895	-17%	-$7.44M	6.6%	7
2018 Q4	$42.1M	Sell	672,456 -52,770	-7%	-$3.69M	5.3%	3
2018 Q3	$56M	Buy	725,226 +196,473	+37%	+$14.8M	3.56%	5
2018 Q2	$37.5M	Buy	528,753 +97,678	+23%	+$6.9M	2.59%	20
2018 Q1	$32.5M	Buy	431,075 +49,840	+13%	+$3.96M	2.83%	13
2017 Q4	$27.3M	Buy	381,235 +77,500	+26%	+$5.89M	3.7%	12
2017 Q3	$24.6M	Buy	303,735 +37,235	+14%	+$2.85M	5.17%	3
2017 Q2	$18.9M	Buy	266,500 +80,000	+43%	+$5.32M	5.6%	5
2017 Q1	$12.7M	Buy	+186,500	New	+$13.1M	4.82%	4

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Chiron Investment Management's GILD Position: Q3 2023 in Review

Chiron Investment Management sold out of Gilead Sciences (GILD) in Q3 2023, closing a stake of 415 shares — an estimated $32K sold.

Chiron Investment Management first reported a position in GILD in Q1 2017 and held it in 15 quarters. The position peaked at $56M in Q3 2018. 1,681 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

Chiron Investment Management reported no remaining Gilead Sciences position as of Q3 2023 after selling out during the quarter.
Chiron Investment Management sold 415 Gilead Sciences shares in Q3 2023, an estimated $32K.
Chiron Investment Management first reported a position in Gilead Sciences in Q1 2017 and held it in 15 quarters.
Chiron Investment Management's Gilead Sciences position peaked at $56M in Q3 2018.
1,681 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on Chiron Investment Management's 13F filing for Q3 2023, filed 13 Nov 2023.